Table 2.
Selected clinical trials of venetoclax in non-Hodgkin lymphomas (NHLs).
| Clinicaltrials.Gov Identifier | Other Study ID Numbers | Intervention | Disease | Study Phase(s) | Publications |
|---|---|---|---|---|---|
| VEN monotherapy | |||||
| NCT01328626 | M12-175 | VEN | R/R NHL (including MCL, FL, DLBCL, RT-DLBCL, WM, and MZL) | 1 | [74] |
| VEN combination therapy | |||||
| NCT02471391 | 14/148, AIM | VEN + IBR | MCL | 2 | [75] |
| NCT03112174 | PCYC-1143-CA, SYMPATICO | VEN + IBR | MCL | 3 | N/A |
| NCT02055820 | GO27878, 2013-003749-40, CAVALLI | VEN + R-/G-CHOP | NHL (including FL and DLBCL) | 1b/2 | [76] |